Year |
Citation |
Score |
2011 |
Bhattacharya S, Chakrabarty B, Kundu PK, Maji A, Ghosal SR, Dey KK. Prevalence of HIV seropositivity among surgical patients in a tertiary care hospital. Journal of the Indian Medical Association. 109: 896-8. PMID 23469570 |
0.375 |
|
2007 |
Vermeire K, Lisco A, Grivel JC, Scarbrough E, Dey K, Duffy N, Margolis L, Bell TW, Schols D. Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity. Biochemical Pharmacology. 74: 566-78. PMID 17603023 DOI: 10.1016/J.Bcp.2007.05.018 |
0.734 |
|
2007 |
VERMEIRE K, LISCO A, GRIVEL J, BLANK P, SCHRAM V, DUFFY N, SCARBROUGH E, DEY K, BELL T, MARGOLIS L. Design and Cellular Kinetics of Dansyl-labeled CADA Derivatives with Specific Anti-HIV and CD4 Receptor Down-modulating Properties Antiviral Research. 74: A68-A69. DOI: 10.1016/J.Antiviral.2007.01.109 |
0.691 |
|
2006 |
Bell TW, Anugu S, Bailey P, Catalano VJ, Dey K, Drew MG, Duffy NH, Jin Q, Samala MF, Sodoma A, Welch WH, Schols D, Vermeire K. Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues. Journal of Medicinal Chemistry. 49: 1291-312. PMID 16480266 DOI: 10.1021/Jm0582524 |
0.428 |
|
2004 |
Vermeire K, Princen K, Hatse S, De Clercq E, Dey K, Bell TW, Schols D. CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro. Aids (London, England). 18: 2115-25. PMID 15577644 DOI: 10.1097/00002030-200411050-00003 |
0.651 |
|
2002 |
Vermeire K, Zhang Y, Princen K, Hatse S, Samala MF, Dey K, Choi HJ, Ahn Y, Sodoma A, Snoeck R, Andrei G, De Clercq E, Bell TW, Schols D. CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor. Virology. 302: 342-53. PMID 12441078 DOI: 10.1006/Viro.2002.1624 |
0.667 |
|
Show low-probability matches. |